<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03619941</url>
  </required_header>
  <id_info>
    <org_study_id>LMS/PGR/UH/03319</org_study_id>
    <nct_id>NCT03619941</nct_id>
  </id_info>
  <brief_title>Continuous Tart Cherry Juice Supplementation With Metabolic Syndrome Participants</brief_title>
  <official_title>Effects of 7-day Continuous Montmorency Tart Cherry Juice Supplementation in Metabolic Syndrome Participants: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Hertfordshire</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Hertfordshire</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study examined the effect of Montmorency tart cherry juice on functional and
      blood-based cardio-metabolic markers in humans with Metabolic Syndrome. Participants consumed
      Montmorency tart cherry juice or a placebo beverage continuously for 7 days in a randomised,
      crossover trial. Outcome variables were measured immediately prior to supplementation and
      post-supplementation. Furthermore, on the 7th day of supplementation outcome variables were
      measured pre- and up to 5 hours post-bolus. It was hypothesised that Montmorency tart cherry
      juice would improve cardio-metabolic markers, particularly fasting insulin and systolic blood
      pressure. Furthermore, the study aimed to identify the mechanism of action for any effects of
      Montmorency tart cherry juice on blood pressure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2018</start_date>
  <completion_date type="Actual">September 29, 2018</completion_date>
  <primary_completion_date type="Actual">September 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Fasting Insulin</measure>
    <time_frame>Baseline, Post-Supplementation (7 days) and Acute Post-Bolus (1 hour, 3 hour, 5 hour)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Systolic and Diastolic Blood Pressure</measure>
    <time_frame>Baseline, Post-Supplementation (7 days) and Acute Post-Bolus (30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 5 hour)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Fasting Lipid Profile (Total Cholesterol, HDL, Triglycerides, LDL)</measure>
    <time_frame>Baseline, Post-Supplementation (7 days) and Acute Post-Bolus (1 hour, 3 hour, 5 hour)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Fasting Glucose</measure>
    <time_frame>Baseline, Post-Supplementation (7 days) and Acute Post-Bolus (1 hour, 3 hour, 5 hour)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in 24-hour Ambulatory Blood Pressure</measure>
    <time_frame>Baseline, Post-Supplementation (7 days)</time_frame>
    <description>Systolic, Diastolic and Pulse Pressure will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HOMA2-IR, HOMA%S and HOMA%B</measure>
    <time_frame>Baseline, Post-Supplementation (7 days)</time_frame>
    <description>Homeostatic Model Assessment of Insulin Resistance, Sensitivity and Beta-cell function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pulse Wave Analysis</measure>
    <time_frame>Baseline, Post-Supplementation (7 days) and Acute Post-Bolus (30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 5 hour)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cardiac Haemodynamics</measure>
    <time_frame>Baseline, Post-Supplementation (7 days) and Acute Post-Bolus (30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 5 hour)</time_frame>
    <description>Beat-by-beat cardiac output, stroke volume, heart rate, total peripheral resistance, mean arterial pressure will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Resting Metabolic Rate</measure>
    <time_frame>Baseline, Post-Supplementation (7 days) and Acute Post-Bolus (30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 5 hour)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Angiotensin Converting Enzyme Inhibition activity</measure>
    <time_frame>Baseline, Post-Supplementation (7 days) and Acute Post-Bolus (1 hour, 3 hour, 5 hour)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Insulin Resistance</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Montmorency Tart Cherry Juice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Montmorency Tart Cherry Juice</intervention_name>
    <description>100% natural, tart Montmorency cherry concentrate (30mL) diluted with 100mL water.
Concentrate contains no sweeteners, preservatives, flavourings or added sugar.</description>
    <arm_group_label>Montmorency Tart Cherry Juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo drink attempted to match for total energy content, macronutrient content, appearance and taste of Montmorency tart cherry juice.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Meet 3 of 5 criteria for Metabolic Syndrome based on National Cholesterol Education
        Program-Adult Treatment Panel III guidelines:

          1. Waist Circumference: &gt;102cm (men), &gt;88cm (women)

          2. Fasting Serum Triglycerides: ≥1.69 mmol.L-1

          3. Fasting High Density Lipoprotein: &lt;1.03 mmol.L-1 (men), &lt;1.29 mmol.L-1 (women)

          4. Blood Pressure: ≥130 mmHg SBP or ≥85 mmHg DBP

          5. Fasting Plasma Glucose: ≥6.1 mmol.L-1

        Exclusion Criteria:

          -  Smokers

          -  Current or previous history of gastrointestinal, cardiovascular, hepatic or renal
             disease

          -  Currently diagnosed with diabetes or uncontrolled hypertension (≥160/100 mmHg)

          -  Allergy to fructose, maltodextrin or specific fruit products

          -  Currently taking medication (such as steroids, NSAIDs, antibiotics, antihypertensive,
             hypoglycaemic, lipid-lowering drugs)

          -  Currently using any nutritional or antioxidant supplement. Heavy alcohol consumption
             (&gt;14 units per week).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terun Desai</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Hertfordshire</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Hertfordshire</name>
      <address>
        <city>Hatfield</city>
        <state>Hertfordshire</state>
        <zip>AL10 9AB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>July 29, 2018</study_first_submitted>
  <study_first_submitted_qc>August 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2018</study_first_posted>
  <last_update_submitted>February 15, 2019</last_update_submitted>
  <last_update_submitted_qc>February 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Hertfordshire</investigator_affiliation>
    <investigator_full_name>Terun Desai</investigator_full_name>
    <investigator_title>PhD Student</investigator_title>
  </responsible_party>
  <keyword>Montmorency Tart Cherry</keyword>
  <keyword>Anthocyanins</keyword>
  <keyword>Polyphenols</keyword>
  <keyword>Metabolic Syndrome</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Lipid Profile</keyword>
  <keyword>Prediabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

